FDA Approves First Oral Treatment for Postpartum Depression ZURZUVAETM (zuranolone)

https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217369s000lbl.pdf?utm_medium=email&utm_source=govdelivery